Login / Signup

Acquired Factor XIII Deficiency Is Common during ECMO Therapy and Associated with Major Bleeding Events and Transfusion Requirements.

Matthias NoitzRoxane BrooksJohannes SzaszDennis JennerCarl BöckNiklas KrennerMartin W DünserJens Meier
Published in: Journal of clinical medicine (2023)
In this retrospective single centre study, acquired factor XIII deficiency was observed in 69% of adult ECMO patients with a high bleeding risk. Factor XIII deficiency was associated with higher rates of major bleeding events and transfusion requirements.
Keyphrases
  • extracorporeal membrane oxygenation
  • atrial fibrillation
  • acute respiratory distress syndrome
  • cardiac surgery
  • replacement therapy
  • risk factors
  • respiratory failure
  • young adults